Pathology · Eumycetoma

Diagnostic Tests and Pathology

At a Glance

Eumycetoma diagnosis combines imaging to map the infection with deep tissue or grain testing to identify the fungus. Ultrasound and MRI show spread, while microscopy, culture, and PCR help distinguish fungal species and guide antifungal treatment.

Because eumycetoma can look identical to other conditions on the surface, your medical team uses imaging and laboratory tests to support the diagnosis ^[1]. This process is about identifying the specific infection and mapping exactly how far the infection has spread ^[2]^[3].

Imaging: Mapping the Infection

Before starting treatment, your doctor needs to see how deep the infection has traveled.

Ultrasound: This is often the first step. It is very effective at showing small cavities and clusters of grains deep under the skin ^[4]. Ultrasound echo patterns can often provide clues to help doctors tell the difference between fungal and bacterial infections, though it cannot replace laboratory testing ^[3].
MRI (Magnetic Resonance Imaging): This is excellent for mapping soft tissue infection ^[5]. MRI can identify a specific pattern called the “dot-in-circle” sign, where the “dot” is the grain and the “circle” is the inflammatory tissue surrounding it ^[6]. While suggestive of mycetoma, it can occur in both eumycetoma and actinomycetoma. MRI helps your surgeon see if the infection has reached your muscles, tendons, or joints ^[7].
X-rays and CT Scans: These are used specifically to check for bone involvement ^[8]. If the infection has reached the bone, it may create small “punched-out” holes that these scans can detect ^[9].

Pathology: Identifying the Fungus

To know which medicine will work, the lab must examine deep tissue or representative grains ^[3]. A superficial swab is often insufficient.

Histopathology: A pathologist looks at a thin slice of tissue under a microscope. They use special dyes, such as PAS (Periodic Acid-Schiff) and GMS (Grocott-Gomori Methenamine Silver), which act like “highlighters” to make the fungal threads (hyphae) visible ^[10]^[11].
Fungal Culture: The lab attempts to grow the organism in a petri dish. This is helpful but can be slow; some species take up to 21 days to grow, and sometimes they refuse to grow at all ^[3].
Molecular PCR Testing: When available, DNA sequencing or PCR testing can be used as an adjunct to help identify the fungus ^[3]. By looking at the DNA of the fungus, doctors can distinguish between species like Madurella mycetomatis and Fusarium ^[12]^[13]. However, its performance depends on the specimen and assay, and it may not be universally available.

Why the Exact Species Matters

Identifying the “name” of the fungus (speciation) is helpful because different fungi respond differently to medications ^[14]. For example, Madurella species are usually treated with certain azole antifungals, but other rare fungi might be resistant to standard drugs ^[15]^[16]. Without knowing the exact species, you might spend months on a medication that the fungus is naturally resistant to ^[17]. However, treatment may need to begin on the best available evidence if speciation is not possible.

Completeness Checklist

When you receive your lab or pathology report, check for these key elements. If they are missing, you should ask your doctor for more information:

[ ] Specimen Type: Does the report confirm they tested a deep biopsy or actual grains?
[ ] Organism Type: Does it clearly distinguish between fungal hyphae and bacterial filaments? (This confirms it is eumycetoma, not actinomycetoma) ^[10].
[ ] Grain Color: Is the color of the grains (e.g., black, white) noted? (Note: color is a clue, not definitive proof of species) ^[18].
[ ] Stains Used: Does the report mention using PAS or GMS stains? ^[10].
[ ] Speciation: Is a specific fungal name (like Madurella mycetomatis) listed, or does it only say “fungal elements seen”? ^[3].
[ ] Bone Status: (If imaging was done) Does the report state whether there is bone invasion or osteomyelitis? ^[7].

Common questions in this guide

What tests are used to diagnose eumycetoma?

Doctors usually combine imaging with laboratory testing. Ultrasound and MRI show the depth and spread of the infection, while a deep tissue biopsy or representative grains can be examined by microscopy, culture, or PCR to identify the fungus.

Is a superficial swab enough to confirm eumycetoma?

A superficial swab is often not enough because it may not represent the organisms deep in the infection. A deep biopsy or a sample of representative grains is generally more useful for microscopy, culture, and molecular testing.

What does the dot-in-circle sign on an MRI mean?

The dot-in-circle sign describes a grain surrounded by inflammatory tissue and can support a diagnosis of mycetoma. It can occur in both fungal eumycetoma and bacterial actinomycetoma, so it cannot identify the type of infection by itself.

Which stains are used to find fungal elements in a biopsy?

PAS and GMS stains are special laboratory dyes that can make fungal threads, called hyphae, easier to see under a microscope. Finding fungal hyphae supports eumycetoma, while bacterial filaments suggest actinomycetoma.

How long does a fungal culture for eumycetoma take?

Some fungi can take up to 21 days to grow, and a culture may not grow even when infection is present. Doctors interpret culture results alongside the tissue examination, imaging findings, and clinical picture.

Why does the exact fungus species matter for treatment?

Different fungi can respond differently to antifungal medicines, and some may be naturally resistant to standard drugs. Madurella species are often treated with azole antifungals, but treatment may need to begin using the best available evidence if the species cannot be identified.

What should I look for in my eumycetoma pathology and imaging reports?

A report should identify whether the sample came from a deep biopsy or representative grains and whether it shows fungal hyphae or bacterial filaments. It may also document grain color, PAS or GMS staining, the identified species, and whether imaging shows bone involvement.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on eumycotic mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Has a biopsy or needle aspiration been done to collect actual grains for testing?
2.Does my pathology report show fungal hyphae (eumycetoma) or bacterial filaments (actinomycetoma)?
3.Was PAS or GMS staining used on my tissue sample to highlight the fungus?
4.Has my sample been sent for PCR or DNA sequencing to identify the exact species of fungus?
5.What did the MRI or ultrasound show regarding 'dot-in-circle' signs or bone involvement?
6.Is there a plan for a fungal culture, and how long will we wait for those results?

References (18)

1
Mycetoma imaging: the best practice.
Bahar ME, Bakheet OELH, Fahal AH
Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):387-396 doi:10.1093/trstmh/traa178.
PMID: 33537774
2
Mycetoma: reviewing a neglected disease.
Verma P, Jha A
Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.
PMID: 29808607
3
Comparing the performance of the common used eumycetoma diagnostic tests.
Siddig EE, Nyuykonge B, Mhmoud NA, et al.
Mycoses 2023; (66(5)):420-429 doi:10.1111/myc.13561.
PMID: 36583225
4
Characterization of Foot Mycetoma Using Sonography and Color Doppler Imaging.
Gameraddin M, Gareeballah A, Mokhtar S, et al.
Pakistan journal of biological sciences : PJBS 2020; (23(7)):968-972 doi:10.3923/pjbs.2020.968.972.
PMID: 32700845
5
Clinico-radiological-pathological correlation in eumycetoma spectrum: Case series.
Yadav T, Meena VK, Shaikh M, et al.
Northern clinics of Istanbul 2020; (7(4)):400-406 doi:10.14744/nci.2019.98215.
PMID: 33043268
6
Madura foot: Atypical MRI presentation beyond the classic dot-in-circle sign.
Mohammed Shobe S, Zeleke B, Getnet S, et al.
Radiology case reports 2026; (21(5)):1989-1993 doi:10.1016/j.radcr.2026.01.059.
PMID: 41756548
7
Advanced Eumycetoma of the Right Foot Resulting in Below-Knee Amputation in Somalia: A Case Report.
Mahamud MA, Ahmed MM, Hassan SA, et al.
International medical case reports journal 2026; (19()):633948 doi:10.2147/IMCRJ.S633948.
PMID: 42808000
8
Hand Mycetoma: The Mycetoma Research Centre Experience and Literature Review.
Omer RF, Seif El Din N, Abdel Rahim FA, Fahal AH
PLoS neglected tropical diseases 2016; (10(8)):e0004886 doi:10.1371/journal.pntd.0004886.
PMID: 27483367
9
Imaging of Madura foot: Case report.
Rais A, Bouardi NE, Bouanani Z, et al.
Radiology case reports 2024; (19(11)):4747-4750 doi:10.1016/j.radcr.2024.07.042.
PMID: 39228927
10
Histopathological Diagnosis of Eumycetoma With Paraspinal Sinuses: A Rare Case Report.
Sonone PP, Hiwale KM
Cureus 2022; (14(9)):e29634 doi:10.7759/cureus.29634.
PMID: 36320972
11
Diagnosis and Management of a Long-Standing Eumycetoma of the Wrist in Somalia: A Case Report in a Resource-Limited Setting.
Mohamed AA, Hassan SA, Hassan MMM
International medical case reports journal 2026; (19()):565197 doi:10.2147/IMCRJ.S565197.
PMID: 41531532
12
The First Case of Fusarium falciforme Eumycetoma in Sudan and an Extensive Literature Review about Treatment Worldwide.
Siddig EE, Ahmed A, Eltigani HF, et al.
Journal of fungi (Basel, Switzerland) 2023; (9(7)) doi:10.3390/jof9070730.
PMID: 37504719
13
Direct 16S/ITS rRNA Gene PCR Followed by Sanger Sequencing for Detection of Mycetoma Causative Agents in Dakar, Senegal: A Pilot Study Among Patients with Mycetoma Attending Aristide Le Dantec University Hospital.
Diongue K, Dione JN, Diop A, et al.
Mycopathologia 2024; (189(5)):80 doi:10.1007/s11046-024-00891-w.
PMID: 39249620
14
Madurella real-time PCR, a novel approach for eumycetoma diagnosis.
Arastehfar A, Lim W, Daneshnia F, et al.
PLoS neglected tropical diseases 2020; (14(1)):e0007845 doi:10.1371/journal.pntd.0007845.
PMID: 31940343
15
In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.
Ahmed SA, de Hoog GS, Stevens DA, et al.
Medical mycology 2015; (53(3)):295-301 doi:10.1093/mmy/myu098.
PMID: 25631481
16
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Nyuykonge B, Lim W, van Amelsvoort L, et al.
Mycoses 2022; (65(6)):650-655 doi:10.1111/myc.13442.
PMID: 35398930
17
Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan.
Mhmoud NA, Siddig EE, Nyuykonge B, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):426-430 doi:10.1093/trstmh/trab010.
PMID: 33515449
18
Cervicofacial Actinomycetoma Presenting with Black Grain: A Rare Clinical Scenario.
Lodha S, Biswas S, Basu A, et al.
The Journal of the Association of Physicians of India 2024; (72(8)):83-85 doi:10.59556/japi.72.0531.
PMID: 39163074

This page explains eumycetoma imaging and laboratory testing for informational purposes only and does not constitute medical advice. Ask your treating doctor, pathologist, or surgeon to interpret your reports and recommend testing for your situation.

Guide Contents